OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression
Yongxi Zhang, Shuyuan Liu, Tiesuo Zhao, et al.
Oncology Reports (2021) Vol. 46, Iss. 2
Open Access | Times Cited: 39
Yongxi Zhang, Shuyuan Liu, Tiesuo Zhao, et al.
Oncology Reports (2021) Vol. 46, Iss. 2
Open Access | Times Cited: 39
Showing 26-50 of 39 citing articles:
METTL3 inhibits BMSC apoptosis and facilitates osteonecrosis repair via an m6A-IGF2BP2-dependent mechanism
Zhihong Xie, Hong Luo, Tao Wang, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e30195-e30195
Open Access | Times Cited: 2
Zhihong Xie, Hong Luo, Tao Wang, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e30195-e30195
Open Access | Times Cited: 2
M2-TAMs promote immunoresistance in lung adenocarcinoma by enhancing METTL3-mediated m6A methylation
Lige Wu, Daoan Cheng, Xin Yang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1380-1380
Open Access | Times Cited: 11
Lige Wu, Daoan Cheng, Xin Yang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1380-1380
Open Access | Times Cited: 11
The Epitranscriptome in miRNAs: Crosstalk, Detection, and Function in Cancer
Daniel del Valle Morales, Patricia Le, Michela Saviana, et al.
Genes (2022) Vol. 13, Iss. 7, pp. 1289-1289
Open Access | Times Cited: 9
Daniel del Valle Morales, Patricia Le, Michela Saviana, et al.
Genes (2022) Vol. 13, Iss. 7, pp. 1289-1289
Open Access | Times Cited: 9
Methyltransferase‐like 3 promotes the progression of lung cancer via activating PI3K /AKT /mTOR pathway
Feng‐Wu Cheng, Li‐Ming Peng, Dan Luo
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 7, pp. 748-758
Closed Access | Times Cited: 8
Feng‐Wu Cheng, Li‐Ming Peng, Dan Luo
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 7, pp. 748-758
Closed Access | Times Cited: 8
Sulforaphene suppressed cell proliferation and promoted apoptosis of COV362 cells in endometrioid ovarian cancer
YU Hui-yan, Yang Li, Yuan-Cai Liu, et al.
PeerJ (2023) Vol. 11, pp. e16308-e16308
Open Access | Times Cited: 4
YU Hui-yan, Yang Li, Yuan-Cai Liu, et al.
PeerJ (2023) Vol. 11, pp. e16308-e16308
Open Access | Times Cited: 4
Guangsi He, Kangsheng Gu, Jie Wei, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 11, pp. 919-928
Open Access | Times Cited: 1
METTL3-mediated m6A methylation of DNMT1 promotes the progression of non-small cell lung cancer by regulating the DNA methylation of FOXO3a
Wenhai Li, Yi Dang, Liang Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28618-e28618
Open Access | Times Cited: 1
Wenhai Li, Yi Dang, Liang Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28618-e28618
Open Access | Times Cited: 1
Yuqiu Liu, Changzhong Li, Qianqian Deng, et al.
The FASEB Journal (2024) Vol. 38, Iss. 11
Open Access | Times Cited: 1
Continued attention: The role of exosomal long non-coding RNAs in tumors over the past three years
Jiarui Cao, Bo Feng, Yanchao Xv, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113666-113666
Open Access | Times Cited: 1
Jiarui Cao, Bo Feng, Yanchao Xv, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113666-113666
Open Access | Times Cited: 1
m6A methyltransferase METTL3 promotes non-small-cell lung carcinoma progression by inhibiting the RIG-I-MAVS innate immune pathway
Tinghui Huang, Xudong Ao, Jie Liu, et al.
Translational Oncology (2024) Vol. 51, pp. 102230-102230
Open Access | Times Cited: 1
Tinghui Huang, Xudong Ao, Jie Liu, et al.
Translational Oncology (2024) Vol. 51, pp. 102230-102230
Open Access | Times Cited: 1
Current and potential roles of RNA modification-mediated autophagy dysregulation in cancer
Hua Huang, Ruining Pan, Sijia Wang, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 736, pp. 109542-109542
Closed Access | Times Cited: 3
Hua Huang, Ruining Pan, Sijia Wang, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 736, pp. 109542-109542
Closed Access | Times Cited: 3
Effect of Polyphenols and Zinc Co-Supplementation on the Development of Neoplasms in Rats with Breast Cancer
Martyna Jastrzębska, Joanna Giebułtowicz, Andrzej K. Ciechanowicz, et al.
Foods (2023) Vol. 12, Iss. 2, pp. 356-356
Open Access | Times Cited: 2
Martyna Jastrzębska, Joanna Giebułtowicz, Andrzej K. Ciechanowicz, et al.
Foods (2023) Vol. 12, Iss. 2, pp. 356-356
Open Access | Times Cited: 2
The therapeutic potential of RNA m(6)A in lung cancer
Jian Yu, Sun Wei, Xiangxuan Zhao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Jian Yu, Sun Wei, Xiangxuan Zhao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Recent Advances in RNA m6A Modification in Solid Tumors and Tumor Immunity
Michelle Verghese, Emma Wilkinson, Yu‐Ying He
Cancer treatment and research (2023), pp. 95-142
Closed Access
Michelle Verghese, Emma Wilkinson, Yu‐Ying He
Cancer treatment and research (2023), pp. 95-142
Closed Access
